Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (415)	2/15/2000 3:45:00 PM
From: 5handicap	Read Replies (1) \| Respond to of 1137

Hi Chris, I tend to believe that the sell off didn't have much to do with the press release today. After all it won't it be 2 years minimum before any CPX revenue shows up? Zadaxin has been driving the stock price and will for the forseeable future I think. Sciclone is a great buy right now..year 2000 revenues will be between $17 to $20 million if not more...growing at over 100%/year..and the company's market cap is only $200 million. Today was just normal stock trading, some large buyers wanted to get filled below $9.